home > news > detailed info

PCI Pharma Services Appoints New Chief Financial Officer SVP Serge Dupuis

PCI Pharma Services

Philadelphia, PA – 22 March, 2019. Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer (CFO).

Serge’s appointment supports PCI’s continued strategic growth and expansion across its global network, currently spanning 20 facilities in eight locations across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.

Serge brings to PCI more than 20 years’ experience in senior leadership roles, mainly in manufacturing environments. He joins the organization from CSP Technologies where he held the role of CFO. Prior to this, Serge served in significant senior-level roles with a range of internationally-recognized manufacturing and services, logistics and defense companies.

In welcoming Serge to PCI, Chief Executive Officer Salim Haffar said: “We are delighted Serge is joining us during this transformative time in PCI’s growth. His appointment is significant; confirming our long-standing commitment to partnering with leading pharmaceutical and biotech companies and help bring their life-saving medicines to patients around the world. Our trusted relationships with our customers are at the heart of all we do; our strategic growth plan, backed by robust global investment, reflects this. Serge will play an invaluable role as we build new capabilities and capacity, supported by innovative technology and first-class equipment – ensuring PCI continues to deliver outstanding quality and service for our clients in both established and emerging global markets.”

Serge added: “I am excited to join the PCI organization, a very successful and unique leader in the pharmaceutical and biotech industry. I believe that PCI is very well-positioned and has a tremendous growth potential based on the impressive reputation, depth of knowledge and sizeable investment.”

PCI recently expanded operations through acquisition, adding key locations in San Diego, Dublin and Melbourne, as well as announcing a record year for capital investment across its global business.

For more information, please visit

About PCI Pharma Services
The global healthcare industry trusts PCI for the development solutions that increase their products' speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enables us to address global needs throughout the product life cycle — from preclinical development, clinical investigational studies, commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients' lives. For more information, please visit or follow us on Twitter at @PCI_Social.

Tom Gosschalk / Carrie Lowe at BECG

T: +44 (0)20 3697 7647 / +44 (0)1962 893 913
phone +44 (0)1495 713 633
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
Print this page
Send to a friend
News and Press Releases

Aptar Pharma Co Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril Portugal

Crystal Lake, Illinois, March 21, 2019 Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement